High Accuracy of Next-Generation Flow (NGF) in Predicting Measurable Residual Disease by Next-Generation Sequencing (NGS) in the 10−6 Range: A Prospective Comparison Within the Phase III IsKia Trial — Mattia D’Agostino (2025) | RDL Network
High Accuracy of Next-Generation Flow (NGF) in Predicting Measurable Residual Disease by Next-Generation Sequencing (NGS) in the 10−6 Range: A Prospective Comparison Within the Phase III IsKia Trial
Maha Hussain, Joaquı́n Mateo, Shahneen Sandhu, Karim Fizazi, Fred Saad, Neal D. Shore, David Olmos, Claire Corcoran, Caroline Sibilla, Alexander Kohlmann, Carrie A. Adelman, Julia A. Elvin, Carsten Goessl, Joseph E. Burgents, Johann S. de Bono
Evangelos Terpos, Ioannis V. Kostopoulos, Efstathios Kastritis, Ioannis Ntanasis‐Stathopoulos, Magdalini Migkou, Pantelis Rousakis, Alexandra Argyriou, Nikolaos Kanellias, Despina Fotiou, Evangelos Eleutherakis‐Papaiakovou, Maria Gavriatopoulou, Dimitrios C. Ziogas, Αριστέα-Μαρία Παπανώτα, Marilyn Spyropoulou-Vlachou, Ioannis P. Trougakos, Ourania Tsitsilonis, Bruno Paiva, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.